We conclude that the polymorphisms 14bp INS/DEL and +3142 C/G of the HLA-G gene mediate gastric cancer risk and survival, and suggest the possibility of establishing new therapeutic approaches aiming at counterbalancing the negative role of this protein in tumors. The gene discussed is HLA-G; the disease is gastric cancer.